Related Experiment Video
Updated: Jun 14, 2025

Fluorescent Leakage Assay to Investigate Membrane Destabilization by Cell-Penetrating Peptide
Published on: December 19, 2020
Development and validation of quality by design stability-indicating method for quantitative determination of
Thamara de Carvalho Mendes1, Rayza Adrielle Dias de Almeida1, Flávia Furtado de Mendonça Sousa1
1Laboratório de Desenvolvimento e Validação Analítica, Instituto de Tecnologia em Fármacos (Farmanguinhos), Fundação Oswaldo Cruz, Rua Sizenando Nabuco, 100, Rio de Janeiro, RJ 21041-250, Brazil.
Abstract:
Analytical Quality by Design (AQbD) enhances analytical methods from the start by integrating scientific principles and risk management. This paper details the development and validation of a high-performance liquid chromatography method for lamivudine and its impurities, using AQbD. The Analytical Target Profile (ATP) was established, followed by a scouting phase and risk assessment. Method parameters were investigated through design of experiments (DoE). The Method Operable Design Region (MODR) was defined using DoE models and Monte Carlo simulations, validation was performed, and a top-down approach estimated measurement uncertainty. During the scouting phase, coelutions were observed. High-risk parameters were explored in the first DoE. Subsequent designs optimized the methanol proportion, buffer concentration and pH. The MODR confirmed the method's robustness. Forced degradation studies showed that lamivudine degrades in acidic, basic and oxidative conditions. The final method utilizes a C18 column at 25 °C, 25 µL injection volume, a flow rate of 1.0 mL/min, a mobile phase A composed by ammonium formate buffer 18,2 mM pH 5.7:methanol (97:3 v/v), and a mobile phase B with a pH of 3.8. An acceptance zone was established using guard bands. AQbD was effectively applied to develop a new analytical method, minimizing the risk of false decisions.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
08:54Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020